Mahkam Zanganeh

Insider Reports History

Entity
Individual
Location
51 Adam Way, Atherton, CA
Signature
/s/ Mahkam Zanganeh
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mahkam Zanganeh:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Summit Therapeutics Inc. Co-Chief Executive Officer, Director Common Stock 25.5M $40.2M $1.58 Oct 3, 2024 By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee
Summit Therapeutics Inc. Co-Chief Executive Officer, Director Common Stock 10.2M $16.1M $1.58 Oct 3, 2024 By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee
Summit Therapeutics Inc. Co-Chief Executive Officer, Director Stock Option (right to buy) 12M $15.8M $1.32 Oct 13, 2023 Direct
PULSE BIOSCIENCES, INC. Director Common Stock 665K $5.69M $8.56 Jul 3, 2024 Direct
PULSE BIOSCIENCES, INC. Director Common Stock 107K $917K $8.56 Jul 3, 2024 Immediate Family Member 3
PULSE BIOSCIENCES, INC. Director Common Stock 27K $231K $8.56 Jul 3, 2024 Immediate Family Member 1
PULSE BIOSCIENCES, INC. Director Common Stock 14K $120K $8.56 Jul 3, 2024 Immediate Family Member 2
Summit Therapeutics Inc. Co-Chief Executive Officer, Director Common Stock 50K $79K $1.58 Oct 3, 2024 Immediate family member
Summit Therapeutics Inc. Co-Chief Executive Officer, Director Common Stock 31K $49K $1.58 Oct 3, 2024 Direct
Summit Therapeutics Inc. Co-Chief Executive Officer, Director Performance Stock Option (right to buy) 2.4M Aug 23, 2024 Direct
PULSE BIOSCIENCES, INC. Director Stock Option (right to buy) 200K Aug 9, 2024 Direct
PULSE BIOSCIENCES, INC. Director Warrant (right to buy) 30.1K Jul 3, 2024 Direct
Summit Therapeutics Inc. Co-Chief Executive Officer, Director Warrant (right to buy) 0 Oct 3, 2024 By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee

Insider Reports Filed by Mahkam Zanganeh

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SMMT Summit Therapeutics Inc. Oct 3, 2024 2 $499K 4 Oct 3, 2024 Co-Chief Executive Officer, Director
SMMT Summit Therapeutics Inc. Sep 11, 2024 1 $1M 4 Sep 13, 2024 Co-Chief Executive Officer, Director
SMMT Summit Therapeutics Inc. Aug 23, 2024 3 $0 4 Aug 23, 2024 Chief Executive Officer, Director
PLSE PULSE BIOSCIENCES, INC. Aug 9, 2024 1 $0 4 Aug 13, 2024 Director
PLSE PULSE BIOSCIENCES, INC. Jul 3, 2024 3 $0 4 Jul 9, 2024 Director
PLSE Pulse Biosciences, Inc. Jun 6, 2024 2 $0 4 Jun 24, 2024 Director
SMMT Summit Therapeutics Inc. Mar 26, 2024 4 $411K 4 Mar 27, 2024 Chief Executive Officer, Director
SMMT Summit Therapeutics Inc. Dec 11, 2023 5 $1.21M 4 Dec 13, 2023 Chief Executive Officer, Director
PLSE Pulse Biosciences, Inc. Nov 13, 2023 4 $163K 4 Nov 15, 2023 Director
SMMT Summit Therapeutics Inc. Oct 13, 2023 1 $0 4 Oct 16, 2023 Chief Executive Officer, Director
PLSE Pulse Biosciences, Inc. Jun 9, 2023 2 $178K 4/A Jul 6, 2023 Director
PLSE Pulse Biosciences, Inc. May 25, 2023 2 $0 4 Jun 6, 2023 Director
SMMT Summit Therapeutics Inc. Mar 8, 2023 2 $24.7M 4/A Mar 13, 2023 Co-CEO & President, Director
SMMT Summit Therapeutics Inc. Dec 6, 2022 1 $0 4 Dec 9, 2022 Co-CEO & President, Director
SMMT Summit Therapeutics Inc. Aug 16, 2022 3 $5.63M 4 Aug 18, 2022 Co-CEO & President, Director
PLSE Pulse Biosciences, Inc. Jun 9, 2022 2 $0 4 Jun 10, 2022 Director
PLSE Pulse Biosciences, Inc. May 19, 2022 2 $0 4 May 23, 2022 Director
SMMT Summit Therapeutics Inc. Dec 15, 2021 1 $0 4 Dec 17, 2021 Chief Operating Officer, Director
PLSE Pulse Biosciences, Inc. May 20, 2021 2 $0 4 May 21, 2021 Director
SMMT Summit Therapeutics Inc. May 12, 2021 1 $2.04M 4 May 14, 2021 Chief Operating Officer, Director